Regarding CRP, only case 2 showed levels above the normal range in all the samples tested, suggesting a baseline inflammatory burden heavier than those of the other patients, with a peak of CRP concentration in the first sample after COVID-19. This evidence concerns the gene CRP and COVID-19.